Ausgabe 02, Januar 2021

Quellenangaben Top Thema


Hsu J, et al. Diagnosing invasive fungal disease in critically ill patients. Crit Rev Microbiol. 2011;37(4):277-312 | Brown G, et al. Tackling human fungal infections. Science. 2012 May 11;336(6082):647 | Fungal Research Trust. How common are fungal diseases? [Internet]. Macclesfield, Cheshire (UK): Fungal Research Trust; 2017 [cited 2019 Aug 1]. Available from: https://www.fungalinfectiontrust.org/how-common-are-fungal-diseases | Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microb Rev. 2007;Jan;20(1):133-63 | Mayer F, et al. Candida albicans pathogenicity mechanisms. Virulence. 2013 Feb 15;4(2):119-28 | Gow N, et al. Candida albicans morphogenesis and host defense: discriminating invasion from colonization. Nat Rev Microbiol. 2011;10:112-2 | Perlroth J, et al. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45:321-46 | Cheng, I, et al. Interplay between Candida albicans and the mammalian innate host defense. Infect Immun. 2012;80(4):1304-13 | Heitman J, et al. Molecular principles of fungal pathogenesis. Emerg Infect Dis. 2006 Oct;12(10):1626–27 | Douglas L, et al. Sur7 promotes plasma membrane organization and is needed for resistance to stressful conditions and to the invasive growth and virulence of Candida albicans. MBio. 2012 Jan- Feb;3(1):e00254-11 | Kim J, Sudbery P. Candida albicans, a major human fungal pathogen. J Microbiol. 2011 Apr;49(2):171-7 | Tani N, et al. Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans. Eur J Med Chem. 2012;47(1):270-7 | Yan L, et al. Disruption of the intestinal mucosal barrier in Canda albicans infections. Microbiol Res. 2013 Aug 25;168(7):389-95 | Kumamoto C. Inflammation and gastrointestinal Candida colonization. Curr Opin Micobiol. 2011 Aug;14(4):386-91 | Brzozowski T, et al. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol. 2005 Mar;40(3):286-96 | Poulain D, et al. Yeasts: neglected pathogens. Dig Dis. 2009;27 Suppl 1:104-10 | Pineton de Chambrun G, et al. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol. 2008 Jul;24(4):440-7 | Standaert-Vitse A, et al. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol. 2009 Jul;104(7):1745-53 | Epstein JB, Polsky B. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin Ther. 1998 Jan-Feb;20(1):40-57 | Epstein JB, Polsky B. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin Ther. 1998 Jan-Feb;20(1):40-57 | Rautema R, Ramage G. Oral candidosis—clinical challenges of a biofilm disease. Crit Rev Microbiol. 2011;37(4):328-36 | Danna PL, et al. Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet. 1991 Mar 2;337(8740):511-4 | Pirotta M, Garland S. Genital candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol. 2006 Sept;44(9):3213-7 | Fattorusso A, et al. Autism spectrum disorders and the gut microbiota. Nutrients 2019 Mar;11(3):521 | Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr. Opin. Pediatr. 2002;14:583–7 | Adams J, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab. 2011;8:34 | Kantarcioglu A, et al. Microbiota-gut-brain axis: yeast species isolated from stool samples of children with suspected or diagnosed autism spectrum disorders and in vitro susceptibility against nystatin and fluconazole. Mycopathologia. 2016;181:1–7 | Iovene M, et al. Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders. Mycopathologia. 2017;182:349–63 | Strati F, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017;5:24 | Manohar V, et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001 Dec;228(1-2):111-7 | Pozzatti P, et al. Comparison of the susceptibilities of clinical isolates of Candida albicans and Candida dubliniensis to essential oils. Mycoses. 2010 Jan;53(1):12-5 | Drugs and Lactation Database, Oregano, www.ncbi.nlm.nih.gov/books/NBK501844/#_ncbi_dlg_citbx_NBK501844, Zugriff 24.09.2020 | Marinelli, L., Di Stefano, A. & Cacciatore, I. Carvacrol and its derivatives as antibacterial agents. Phytochem Rev 17, 903–921 (2018) | Friedmann, M. Chemistry and Multibeneficial Bioactivities of Carvacrol (4-Isopropyl-2-methylphenol), a Component of Essential Oils Produced by Aromatic Plants and SpicesJ. Agric. Food Chem. 2014, 62, 31, 7652–7670 | G. et al. Evaluation of in vitro activity of carvacrol against Candida albicans strains Natural Product Research 2010 (12), 1189-1193 | Jacobsen PJ. Candida versus breastfeeding--which is winning? Midwifery Today Int Midwife. 2009;26-7, 66 | Raptis, Michael: Was ich über Oregano-Öl sagen wollte. Narayana-Verlag, 2. Auflage, 2020 | Falagas M, et al. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58(2):266-72 | Mailander-Sanchez D, et al. Potential role of probiotic bacteria in the treatment and prevention of localised candidosis. Mycosis. 2012;55(1):17-26 | Krasowska A, et al. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res. 2009 Dec;9(8):1312-21 | Murzyn A, et al. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 2010 Aug 10;5(8):e12050 | Manzoni P. Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates. J Pediatr Gastroenterol Nutr. 2007 Dec;45 Suppl 3:S190-4 | Zwolińska-Wcisło M, et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol. 2006 Nov;57 Suppl 9:35-49 | Ogbolu DO, et al. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food. 2007 Jun;10(2):384-7 | Adams J, et al. Effects of sodium caprylate on Candida albicans. I. Influence of concentration on ultrastructure. J Bacteriol. 1963 Sep;86:548-57 | Rosenblatt J, et al. Caprylic acid and glyceryl trinitrate combination for eradication of biofilm. Antimicrob Agents Chemother. 2015;59(3):1786-88 | Jadhav A, et al. The dietary food components capric acid and caprylic acid inhibit virulence factors in Candida albicans through multitargeting. J Medicinal Food. 2017 Nov;20(11):1083-90 | Herlea V. Antifungal effects of the antimicrobial factors in human milk and colostrum in mixed bacterial and fungal cultures. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1985 Jan- Mar;30(1):43-8 | Al-Sheikh H. Effect of lactoferrin and iron on the growth of human pathogenic candida species. Pak J Biol Sci. 2009;12(1):91-4 | Russo R, et al. Randomized clinical trial in women with recurrent vulvovaginal candidiasis: efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019 Apr;62(4):328-35 | Kobayashi T, et al. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis. Jpn J Infect Dis. 2011;64(4):292-6 | Gomez Castellanos J, et al. Red Lapacho (Tabebuia impetiginosa)-a global ethnopharmacological commodity? J Ethnopharmacol. 2009 Jan 12;121(1):1-13 | Guiraud P, et al. Comparison of antibacterial and antifungal activities of lapachol and B-lapachone. 1994 Aug;60(4):373-4. | Vikrant P, et al. Plants with anti-candida activity and their mechanism of action: a review. J Environ Res Develop. 2015 Apr;9(4):1189 | Sytykiewicz H, et al. Antifungal activity of Juglans regia leaf extracts against Candida albicans isolates. Pol J Environ. 2015; 24(3):1339-48 | Strom CM, Levine EM. Chronic vaginal candidiasis responsive to biotin therapy in a carrier of biotinidase deficiency. Obstet Gynecol 1998 Oct;92(4):644-6 | [1] Wolf B, Heard GS. Biotinidase deficiency. Adv Pediatr. 1991;38:1-21.